![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Sun Pharmaceuticals Halol Plant Still in Trouble with FDA after New Report
Sun Pharmaceuticals Halol Plant Still in Trouble with FDA after New Report
![RedWarningStamp.gif](https://www.fdanews.com/ext/resources/test/Device_Images5/RedWarningStamp.gif?t=1576044606&width=430)
A year after receiving a warning letter, Sun Pharmaceuticals’ Halol, India plant has been hit with another Form 483.
That warning letter, issued in December 2015, contained a litany of serious violations, including inadequate written procedures, unexplained failures of drug batches and failures to maintain a clean area in aseptic processing.
The FDA also asked for a new smoke studies, repairs of leaking ceilings and details on how the company planned to redesign its aseptic processing operation.
Upcoming Events
-
21Oct